Article Details

As of March, 20 Analysts See $0.11 EPS for BioSyent Inc. (RX)

Retrieved on: 2019-02-15 13:54:47

Tags for this article:

Click the tags to see associated articles and topics

As of March, 20 Analysts See $0.11 EPS for BioSyent Inc. (RX). View article details on HISWAI:

Excerpt

<div>... (MAD)(NVDA)(ASX)(TSM) – Benzinga” released on February 02, 2018, “<b>Aurora Cannabis Inc</b> (TSE:ACB) CCO Cam Battley on Spin-out and Canopy ...</div>

Article found on:

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up